The DEA is considering reclassifying marijuana as a Schedule III drug, on par with Tylenol 3. We had a drug policy expert weigh the pros and cons: theconversation.com/dea-could-… #health
Moving marijuana to a less restrictive category under the Controlled Substances Act poses benefits and potential risks. But no effective medicine is free from risks.
